With this contract file whose conditions are established in the specifications, it is intended to cover the use of the medication included in the file to meet the clinical needs of Osakidetza patients and related centers that are summarized in the file's report.
Active substance: Amoxicillin / clavulanic acid (DOE)
Amount of active ingredient: 1 000/200 mg and 2 000/200 mg
Pharmaceutical form: vial
Packaging conditions: unit dose
Maximum unit price: 0.92 EUR / vial of 1 000/200 mg and 1.78 EUR / vial of 2 000/200 mg (taxes not included)
Number of planned units: 280 000 vials of 1 000/200 mg and 90 000 vials of 2 000/200 mg
Estimated maximum budget: 417 800.00 EUR (first year of contract)
Active substance: Piperacillin / tazobactam (DOE)
Amount of active ingredient: 2 / 0.25 g and 4 / 0.5 g
Pharmaceutical form: vial
Packaging conditions: unit dose
Maximum unit price: 2.75 EUR / vial of 2 / 0.25 g and 5.50 EUR / vial of 4 / 0.5 g (taxes not included)
Number of planned units: 13,000 vials of 2 / 0.25 g and 285,000 vials of 4 / 0.5 g
Estimated maximum budget: 1 603 250.00 EUR (first year of contract)
Active substance: Methylprednisolone (DOE)
Amount of active ingredient: 8 mg, 20 mg, 40 mg and 250 mg
Pharmaceutical form: ampoule
Packaging conditions: unit dose
Maximum unit price: 0.34 EUR / pack of 1 ampoule of 8 mg, 0.62 EUR / pack of 1 ampoule of 20 mg, 1.36 EUR / pack of 3 ampoules of 20 mg, 0.67 EUR / pack of 1 ampoule of 40 mg, 1.55 EUR / pack of 3 ampoules of 40 mg, 2.26 EUR / pack of 1 ampoule of 250 mg, 11.30 EUR / pack of 5 ampoules of 250 mg and 102.00 EUR / Pack of 50 ampoules of 250 mg (taxes not included)
Number of planned units: 3 500 packages of 1 ampoule of 8 mg, 166 000 packs of 1 ampoule of 20 mg, 3 000 packs of 3 ampoules of 20 mg, 193 000 packs of 1 ampoule of 40 mg, 9 000 packs of 3 ampoules of 40 mg, 10 packs of 1 ampoule of 250 mg, 8 packs of 5 ampoules of 250 mg and 47 packs of 50 ampoules of 250 mg
Estimated maximum budget: 256 357.00 EUR (first year of contract)
Active substance: Methylprednisolone (DOE)
Amount of active ingredient: 20 mg and 40 mg
Pharmaceutical form: vial
Packaging conditions: unit dose
Maximum unit price: 0.58 EUR / pack of 1 vial of 20 mg, 0.77 EUR / pack of 1 vial of 40 mg (taxes not included)
Number of planned units: 175,000 containers of 1 vial of 20 mg, 220,000 containers of 1 vial of 40 mg
Estimated maximum budget: 270 900.00 EUR (first year of contract)
Active substance: Methylprednisolone (DOE)
Amount of active ingredient: 40 mg, 125 mg, 500 mg and 1000 mg
Pharmaceutical form: vial
Packaging conditions: unit dose
Maximum unit price: EUR 41.30 / pack of 100 vials of 40 mg, EUR 1.60 / pack of 1 vial of 125 mg, EUR 2.73 / pack of 3 vials of 125 mg, EUR 45.50 / pack of 50 vials of 125 mg, 4.52 EUR / pack of 1 vial of 500 mg, 258.12 EUR / pack of 50 vials of 500 mg, EUR 7.05 / pack of 1 vial of 1000 mg and 352.50 EUR / pack of 50 vials of 1000 mg (taxes not included)
Number of planned units: 2 200 packs of 100 vials of 40 mg, 60 packs of 1 vial of 125 mg, 30 packs of 3 vials of 125 mg, 77 packs of 50 vials of 125 mg, 50 packs of 1 vial of 500 mg , 15 packs of 1 vial of 500 mg, 250 packs of 1 vial of 1000 mg and 85 packs of 50 vials of 1000 mg
Estimated maximum budget: 130 364.20 EUR (first year of contract)